US FDA has granted clearance of DaylightRx for generalized anxiety disorder
-
learn more here.
Solutions
Research
Company
Get Started
US
Who we serve
Health Systems & Practices
Health Plans
Employers
Safe and effective digital CBT for insomnia and anxiety
offerings
For insomnia
For anxiety
Increase access to first-line mental health care for members
Explore all health plan solutions
offerings
For insomnia
For anxiety
Provide effective mental health care for your organization
Explore all employer solutions
offerings
For better sleep
For improved mood
For reduced worry and anxiety
For comprehensive mental health care
BIG HEALTH
About Us
Our mission & team
News & Resources
Learn with us
Careers
Join our mission
FAQ
We’ve got answers
Our Solutions
Sleepio
Sleepio Rx
Daylight
Daylight Rx
Spark Direct
For Organizations
Research
Resources
Blog
News
Webinars
Reports
Tools
User Stories
Contact Us
Request Demo
US
UK
Latest news
March 24, 2025
/
News
FDA-Cleared Digital Treatments are Shaping the Future of Mental Healthcare
New JAMA Study Showcases Clinical Benefits of SleepioRx in Patients with Comorbid Insomnia and Depression Symptoms, Marking 100+ Peer-Reviewed Papers for Big Health
March 10, 2025
/
News
US FDA Grants Clearance for DaylightRx
September 4, 2024
/
News
US FDA Grants Clearance for SleepioRx
August 8, 2024
/
News
Study Finds Spark Direct Effective in Improving Mood Among Adults With Depression
May 23, 2024
/
News
All News
Big Health and EHIR introduce Mental Health Maturity Index, measuring employer progress toward better mental health
Survey of large employers covering more than two million lives finds companies embracing mental health support but lack meaningful measures of success.
May 25, 2021
/
News
Big Health names mental health equity expert and clinical psychologist, Dr. Juliette McClendon, Director of Medical Affairs
Dr. McClendon will lead the medical affairs function with a focus on increasing the reach of Big Health’s mental health solutions.
May 3, 2021
/
News
Big Health doubles its ‘lives covered’ as COVID-19 drives demand and adoption of solutions for good mental health
Big Health doubled the number of 'lives covered' in 2020 as demand for mental health solutions increase.
March 31, 2021
/
News
New study finds digital CBT the most cost effective option for poor sleep, when compared to other leading choices
Digital Cognitive Behavioral Therapy (dCBT), as delivered by Sleepio, was found to be the most cost-effective intervention overcoming poor sleep.
December 15, 2020
/
News
First of its kind digital therapeutic research identifies poor sleep as a target for improving depressive symptoms
Digital sleep program, Sleepio, associated with significant improvements in depressive symptoms.
August 19, 2020
/
News
Digital therapy for insomnia could save NHS millions and improve anxiety and depression symptoms
New report finds use of Sleepio delivers high recovery rates, improve mental health outcomes & could save the NHS £56 million over three years.
July 31, 2020
/
News
Previous
Load More
Let's talk
For all media-related queries, please get in touch with us.
press@bighealth.com
Who we are
Learn about our mission, leadership, advisors, and investors.
About us